| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $150.2M | +20.8% |
| SG&A Expense | $50.8M | -5.4% |
| Operating Income | -$201.1M | -17.4% |
| Pre-tax Income | -$232.9M | -32.2% |
| Income Tax | $2.8M | +111.4% |
| Net Income | -$235.8M | -56.0% |
| EPS (Basic) | -$2.06 | -31.2% |
| EPS (Diluted) | -$2.06 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $383.2M | +199.3% |
| Short-term Investments | $99.0M | -23.0% |
| Current Assets | $536.4M | +70.2% |
| Total Assets | $576.8M | +60.1% |
| Current Liabilities | $58.0M | +47.3% |
| Long-term Debt | $108.9M | — |
| Total Liabilities | $175.3M | +41.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$142.1M | +11.4% |
| Capital Expenditures | $34K | -79.9% |
| Investing Cash Flow | $31.3M | +124.6% |
| Financing Cash Flow | $364.8M | +1627.3% |
| Free Cash Flow | -$142.1M | +11.5% |
| -31.2% |
| Stockholders' Equity |
| $401.5M |
| +70.0% |